GlaxoSmithKline Blocks Sale Of Generic Flonase
Filed in archive Drugs, Vaccines and Therapeutics , Patents and Intellectual Property Rights by ruth on February 28, 2006

version of Flonase (GlaxoSmithKline), a nasal spray that treats allergic and nonallergic nasal symptoms. GlaxoSmithKline obtained the restraining order one day after the company sued the FDA for allegedly ailed to follow its own regulations in approving the Flonase generic and failed to apply the same quality standards.
See full story from LA Times.
Permalink: GlaxoSmithKline Blocks Sale Of Generic Flonase
Tags:
allergies
nasal
biotech
generic
flonase
generic+flonase
glaxosmithkline+blocks
sale+generic
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/16406

Mr Wong
